Abstract |
The antineoplastic activity of two ether lipid derivatives, the alkyl- lysophospholipid derivative (ALP) ET-18-OCH3 and the ether-linked lipoidal amine CP-46,665 was tested in a human tumor clonogenic assay ( HTCA) in vitro. CP-46,665 suppressed the colony formation of various human tumors with a slight dose response relation after 1 hr incubation and with a clear optimum (85% response rate) after continuous exposure in the higher dose range tested (10 micrograms/ml). ET-18-OCH3 did not have substantial activity after 1 hr of incubation. However, when continuous exposure to the compound was used, ET-18-OCH3 seemed to have a modest dose response effect and yielded a response in about 60% of the tumor cell samples tested in the higher dose range (10 micrograms/ml). Thus, both compounds have in vitro antitumor activity in the HTCA within a dose range of 1-10 micrograms/ml, especially during continuous exposure. The tumor specific type activity was found in breast cancer, ovarian cancer, lung cancer and mesothelioma. Both compounds caused decreases in colony formation down to the 0%, 2% and 4% levels. In a comparison of specimens in which both compounds were used, only one of five times showed a discordance in sensitivity or resistance; therefore the compounds appear similar in their in vitro activity. In a second set of experiments we tested the structure-activity relationship among a variety of ALP in the [3H] thymidine incorporation assay after incubation with HL-60 leukemic blasts and other neoplastic cells from human origin.(ABSTRACT TRUNCATED AT 250 WORDS)
|
Authors | W E Berdel, D D Von Hoff, C Unger, H D Schick, U Fink, A Reichert, H Eibl, J Rastetter |
Journal | Lipids
(Lipids)
Vol. 21
Issue 4
Pg. 301-4
(Apr 1986)
ISSN: 0024-4201 [Print] United States |
PMID | 3713449
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Lysophosphatidylcholines
- Phospholipid Ethers
- Piperidines
- edelfosine
- CP 46665
|
Topics |
- Antineoplastic Agents
(therapeutic use)
- Cell Survival
(drug effects)
- Female
- Humans
- Lysophosphatidylcholines
(therapeutic use, toxicity)
- Neoplasms
(drug therapy, pathology)
- Phospholipid Ethers
- Piperidines
(therapeutic use, toxicity)
- Structure-Activity Relationship
|